201 related articles for article (PubMed ID: 25243774)
1. Montelukast reduces sepsis-induced lung and renal injury in rats.
Khodir AE; Ghoneim HA; Rahim MA; Suddek GM
Can J Physiol Pharmacol; 2014 Oct; 92(10):839-47. PubMed ID: 25243774
[TBL] [Abstract][Full Text] [Related]
2. Montelukast attenuates lipopolysaccharide-induced cardiac injury in rats.
Khodir AE; Ghoneim HA; Rahim MA; Suddek GM
Hum Exp Toxicol; 2016 Apr; 35(4):388-97. PubMed ID: 26089034
[TBL] [Abstract][Full Text] [Related]
3. Chronic renal failure-induced multiple-organ injury in rats is alleviated by the selective CysLT1 receptor antagonist montelukast.
Sener G; Sakarcan A; Sehirli O; Ekşioğlu-Demiralp E; Sener E; Ercan F; Gedik N; Yeğen BC
Prostaglandins Other Lipid Mediat; 2007 Jun; 83(4):257-67. PubMed ID: 17499745
[TBL] [Abstract][Full Text] [Related]
4. The effects of montelukast against amikacin-induced acute renal damage.
Kose E; Beytur A; Dogan Z; Ekincioglu Z; Vardi N; Cinar K; Turkoz Y; Soysal H; Ekinci N
Eur Rev Med Pharmacol Sci; 2012 Apr; 16(4):503-11. PubMed ID: 22696878
[TBL] [Abstract][Full Text] [Related]
5. Leukotriene receptor blocker montelukast protects against burn-induced oxidative injury of the skin and remote organs.
Sener G; Kabasakal L; Cetinel S; Contuk G; Gedik N; Yeğen BC
Burns; 2005 Aug; 31(5):587-96. PubMed ID: 15935562
[TBL] [Abstract][Full Text] [Related]
6. Montelukast protects against renal ischemia/reperfusion injury in rats.
Sener G; Sehirli O; Velioğlu-Oğünç A; Cetinel S; Gedik N; Caner M; Sakarcan A; Yeğen BC
Pharmacol Res; 2006 Jul; 54(1):65-71. PubMed ID: 16584888
[TBL] [Abstract][Full Text] [Related]
7. Cysteinyl leukotriene receptor antagonist montelukast ameliorates acute lung injury following haemorrhagic shock in rats.
Al-Amran FG; Hadi NR; Hashim AM
Eur J Cardiothorac Surg; 2013 Feb; 43(2):421-7. PubMed ID: 22851661
[TBL] [Abstract][Full Text] [Related]
8. Montelukast ameliorates kidney function and urinary bladder sensitivity in experimentally induced renal dysfunction in rats.
Suddek GM
Fundam Clin Pharmacol; 2013 Apr; 27(2):186-91. PubMed ID: 21985664
[TBL] [Abstract][Full Text] [Related]
9. Oxidative renal damage in pyelonephritic rats is ameliorated by montelukast, a selective leukotriene CysLT1 receptor antagonist.
Tuğtepe H; Sener G; Cetinel S; Velioğlu-Oğünç A; Yeğen BC
Eur J Pharmacol; 2007 Feb; 557(1):69-75. PubMed ID: 17173892
[TBL] [Abstract][Full Text] [Related]
10. Preventive and therapeutic effects of Danhong injection on lipopolysaccharide induced acute lung injury in mice.
Wan LM; Tan L; Wang ZR; Liu SX; Wang YL; Liang SY; Zhong JB; Lin HS
J Ethnopharmacol; 2013 Aug; 149(1):352-9. PubMed ID: 23850708
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of sepsis-induced pancreatic injury by leukotriene receptor antagonism via modulation of oxidative injury, and downregulation of inflammatory markers in experimental rats.
Hagar HH; Alhazmi SM; Arafah M; Bayoumy NM
Naunyn Schmiedebergs Arch Pharmacol; 2024 May; 397(5):3425-3435. PubMed ID: 37962585
[TBL] [Abstract][Full Text] [Related]
12. Montelukast abrogates rhabdomyolysis-induced acute renal failure via rectifying detrimental changes in antioxidant profile and systemic cytokines and apoptotic factors production.
Helmy MM; El-Gowelli HM
Eur J Pharmacol; 2012 May; 683(1-3):294-300. PubMed ID: 22449377
[TBL] [Abstract][Full Text] [Related]
13. Amelioration of sepsis-induced hepatic and ileal injury in rats by the leukotriene receptor blocker montelukast.
Sener G; Sehirli O; Cetinel S; Ercan F; Yüksel M; Gedik N; Yeğen BC
Prostaglandins Leukot Essent Fatty Acids; 2005 Dec; 73(6):453-62. PubMed ID: 16162403
[TBL] [Abstract][Full Text] [Related]
14. Febuxostat exerts dose-dependent renoprotection in rats with cisplatin-induced acute renal injury.
Fahmi AN; Shehatou GS; Shebl AM; Salem HA
Naunyn Schmiedebergs Arch Pharmacol; 2016 Aug; 389(8):819-30. PubMed ID: 27215580
[TBL] [Abstract][Full Text] [Related]
15. Montelukast inhibits caspase-3 activity and ameliorates oxidative damage in the spinal cord and urinary bladder of rats with spinal cord injury.
Erşahin M; Çevik Ö; Akakın D; Şener A; Özbay L; Yegen BC; Şener G
Prostaglandins Other Lipid Mediat; 2012 Dec; 99(3-4):131-9. PubMed ID: 22986158
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the effects of a high dose of erythropoietin-beta on early endotoxemia using a rat model.
Eren Z; Coban J; Ekinci ID; Kaspar C; Kantarci G
Adv Clin Exp Med; 2012; 21(3):321-9. PubMed ID: 23214195
[TBL] [Abstract][Full Text] [Related]
17. Beneficial effects of montelukast against cisplatin-induced acute renal damage in rats.
Beytur A; Köse E; Sarihan ME; Sapmaz HI; Dogan Z; Cetin A; Vardi N; Turkoz Y; Ekinci N
Ren Fail; 2012; 34(3):343-9. PubMed ID: 22260262
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment with hydrogen-rich saline reduces the damage caused by glycerol-induced rhabdomyolysis and acute kidney injury in rats.
Gu H; Yang M; Zhao X; Zhao B; Sun X; Gao X
J Surg Res; 2014 May; 188(1):243-9. PubMed ID: 24495844
[TBL] [Abstract][Full Text] [Related]
19. Usnic acid protects LPS-induced acute lung injury in mice through attenuating inflammatory responses and oxidative stress.
Su ZQ; Mo ZZ; Liao JB; Feng XX; Liang YZ; Zhang X; Liu YH; Chen XY; Chen ZW; Su ZR; Lai XP
Int Immunopharmacol; 2014 Oct; 22(2):371-8. PubMed ID: 25068825
[TBL] [Abstract][Full Text] [Related]
20. Effects of ketamine, propofol, and ketofol on proinflammatory cytokines and markers of oxidative stress in a rat model of endotoxemia-induced acute lung injury.
Gokcinar D; Ergin V; Cumaoglu A; Menevse A; Aricioglu A
Acta Biochim Pol; 2013; 60(3):451-6. PubMed ID: 24020061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
